Nagao K - Search Results

1

N-nitroso-fenfluramine hepatotoxicity resembling chronic hepatitis.

Kanda T, Yokosuka O, Tada M, Kurihara T, Yoshida S, Suzuki Y, Nagao K, Saisho H. Kanda T, et al. Among authors: nagao k. J Gastroenterol Hepatol. 2003 Aug;18(8):999-1000. doi: 10.1046/j.1440-1746.2003.03074.x. J Gastroenterol Hepatol. 2003. PMID: 12859734 No abstract available.

2

Corticosteroids and lamivudine combined to treat acute severe flare-up in a chronic hepatitis B and C patient.

Kanda T, Yokosuka O, Imazeki F, Yoshida S, Suzuki Y, Nagao K, Saisho H. Kanda T, et al. Among authors: nagao k. J Gastroenterol Hepatol. 2004 Feb;19(2):238-9. doi: 10.1111/j.1440-1746.2004.03269.x. J Gastroenterol Hepatol. 2004. PMID: 14731142 No abstract available.

3

Hepatitis C infection with history of tuberculosis in Japan: no association with progression of liver fibrosis.

Kanda T, Yokosuka O, Imazeki F, Saisho H, Nagao K. Kanda T, et al. Among authors: nagao k. J Gastroenterol Hepatol. 2004 Jun;19(6):717-9. doi: 10.1111/j.1440-1746.2004.03399.x. J Gastroenterol Hepatol. 2004. PMID: 15151635 No abstract available.

4

Acute-onset autoimmune hepatitis resembling acute hepatitis: a case report and review of reported cases.

Kanda T, Yokosuka O, Hirasawa Y, Imazeki F, Nagao K, Suzuki Y, Saisho H. Kanda T, et al. Among authors: nagao k. Hepatogastroenterology. 2005 Jul-Aug;52(64):1233-5. Hepatogastroenterology. 2005. PMID: 16001669 Review.

5

Prevalence of obesity in patients with acute hepatitis; is severe obesity a risk factor for fulminant hepatitis in Japan?

Kanda T, Yokosuka O, Hiraide A, Kojima H, Honda A, Fukai K, Imazeki F, Nagao K, Saisho H. Kanda T, et al. Among authors: nagao k. Hepatogastroenterology. 2005 Jan-Feb;52(61):180-2. Hepatogastroenterology. 2005. PMID: 15783024

6

[Viral factors and host factors in pathogenesis of fulminant hepatitis, type B].

Kanda T, Nagao K, Yokosuka O, Imazeki F. Kanda T, et al. Among authors: nagao k. Nihon Rinsho. 2004 Aug;62 Suppl 8:259-63. Nihon Rinsho. 2004. PMID: 15453326 Review. Japanese. No abstract available.

7

Occurrence of autoimmune hepatitis during the course of primary biliary cirrhosis: report of two cases.

Kanda T, Yokosuka O, Hirasawa Y, Imazeki F, Nagao K, Saisho H. Kanda T, et al. Among authors: nagao k. Dig Dis Sci. 2006 Jan;51(1):45-6. doi: 10.1007/s10620-006-3083-5. Dig Dis Sci. 2006. PMID: 16416210 No abstract available.

8

Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.

Kanda T, Yokosuka O, Imazeki F, Fujiwara K, Nagao K, Saisho H. Kanda T, et al. Among authors: nagao k. Biochem Biophys Res Commun. 2005 Jun 3;331(2):621-9. doi: 10.1016/j.bbrc.2005.03.212. Biochem Biophys Res Commun. 2005. PMID: 15850805

9

State of hepatitis C viral replication enhances activation of NF-kB- and AP-1-signaling induced by hepatitis B virus X.

Kanda T, Yokosuka O, Nagao K, Saisho H. Kanda T, et al. Among authors: nagao k. Cancer Lett. 2006 Mar 28;234(2):143-8. doi: 10.1016/j.canlet.2005.03.030. Cancer Lett. 2006. PMID: 15885885

10

5-aza-2'-deoxycytidine sensitizes hepatoma and pancreatic cancer cell lines.

Kanda T, Tada M, Imazeki F, Yokosuka O, Nagao K, Saisho H. Kanda T, et al. Among authors: nagao k. Oncol Rep. 2005 Oct;14(4):975-9. Oncol Rep. 2005. PMID: 16142360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,697 results

Search Page

Filters